Target intelligence / Profile preview

Oral mucosal surfaces and salivary proteins

Molecular classification
Glycoprotein, Enzyme, Antimicrobial peptide, Proline-rich protein, Receptor, Other
01

Overview

Oral mucosal surfaces and salivary proteins constitute a complex biological system essential for maintaining oral health and facilitating initial digestive processes. The oral mucosa acts as a physical and immunological barrier, while salivary proteins, including mucins (e.g., MUC5B, MUC7), proline-rich proteins, and antimicrobial peptides like histatins, provide lubrication, buffering, and defense against pathogens (Humphrey & Williamson, 2001, J Prosthet Dent). This system is a primary target for therapies addressing xerostomia (dry mouth), where drugs like pilocarpine stimulate secretion, or mucoadhesive formulations that adhere to the mucosal pellicle for localized drug delivery (Nair & Gopi, 2014, J Basic Clin Pharma). Dysregulation of these components is linked to conditions such as oral mucositis, dental caries, and periodontal disease (NIH, 2023, Oral Health). Understanding the interaction between exogenous compounds and the salivary pellicle—a thin layer of proteins adsorbed onto oral surfaces—is crucial for optimizing topical treatments and protecting the oral cavity from infection and mechanical injury (Vila et al., 2019, Pathogens).

Other names
Oral mucosaSalivary pellicleSalivary proteomeOral cavity liningOral mucosal barrier
02

Mechanism of action

Mechanisms include the stimulation of muscarinic M3 receptors in salivary glands to increase protein and fluid output, the physical coating of mucosal surfaces by mucoadhesive polymers to enhance drug residence time, and the antimicrobial action of proteins like lysozyme and lactoferrin against oral pathogens.

03

Biological functions

LubricationImmune responseDigestionBufferingBarrier functionTissue repairAntimicrobial defense
04

Disease associations

InfectionInflammationXerostomiaOral mucositisDental cariesPeriodontal diseaseSjogren's syndrome
05

Safety considerations

Local irritationDysgeusia (taste disturbance)Systemic cholinergic side effects (e.g., sweating, nausea)Allergic contact stomatitisPotential for increased systemic absorption of topical drugs through compromised mucosa
06

Interacting drugs

Pilocarpine

7 more in the full profile.

07

Biomarkers

Salivary flow rate (SFR)MUC5B concentrationSalivary alpha-amylase (sAA)Secretory immunoglobulin A (sIgA)Salivary pH

Beyond the preview

Go deeper on Oral mucosal surfaces and salivary proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral mucosal surfaces and salivary proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call